Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Project Oncology® - Un pódcast de ReachMD
Categorías:
Host: Pavani Chalasani, MD, MPH Guest: Nick McAndrew, MD, MSCE How can ribociclib plus endocrine therapy help reduce recurrence in early breast cancer? That’s the exact question the NATALEE trial sought to answer, and here to discuss the results with Dr. Pavani Chalasani is Dr. Nicholas McAndrew, Assistant Professor in the Division of Hematology and Oncology at the UCLA David Geffen School of Medicine.
